September 2026
The chemical drug CDMO market size was USD 14.32 billion in 2026, with leading chemical drug CDMO market players including Almac Group, BASF SE, Boehringer Ingelheim, Cipla Limited.
September 2026
The chemical API CDMO market size was USD 18.36 billion in 2026, with leading chemical API CDMO market players including Lonza Group, WuXi AppTec, Samsung Biologics, Boehringer Ingelheim.
August 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
January 2026
The global investigational new drug CDMO market size is estimated to hit around USD 10.90 billion by 2035 from USD 5.61 billion in 2025, with a CAGR of 6.87%.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 864.96 million in 2026, with a CAGR of 9.00%.
September 2026
The drug delivery devices market size reached USD 321.05 billion in 2026, with leading drug delivery devices market companies including Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The drug discovery services market size was estimated at USD 27.89 billion in 2026 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
September 2026
The global thin film drug manufacturing market size is estimated to hit around USD 15.50 billion by 2035, increasing from USD 8.51 billion in 2026, with a CAGR of 6.93%.
September 2026
The global pine derived chemicals market reached USD 6.65 billion in 2026, with key pine derived chemicals companies including Kraton Corporation, Ingevity Corporation, Harima Chemicals Group, Inc.
September 2026
The global orphan drugs market size was surpass to USD 242.97 billion in 2026 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
September 2026
The global chemical sensors market size is calculated at USD 29.25 billion in 2026 and is projected to hit around USD 59.60 billion by 2035 with a CAGR of 8.24%.
September 2026
The atopic dermatitis drugs market size is calculated at USD 17.21 billion in 2026 and is projected to hit around USD 33.42 billion by 2035 with a CAGR of 7.70%.
September 2026
The global hyperlipidemia drugs market size is calculated at USD 24.80 billion in 2026 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
September 2026
The global pediatric drugs market size was estimated at USD 183.20 billion in 2026 and is projected to hit around USD 506.52 billion by 2035 with a CAGR of 11.99%.
September 2026
The global green chemicals market size is calculated at USD 178.38 billion in 2026 and is projected to hit around USD 421.66 billion by 2035 with a CAGR of 10.05%.
September 2026
The specialty oilfield chemicals market size was evaluated at USD 10.57 billion in 2024 and is projected to surge around USD 16.22 billion by 2034 with a CAGR of 4.38%.
September 2026
The global nasal drug delivery technology market size is expected to surge around USD 179.41 billion by 2035 from USD 95.49 billion in 2026, growing at a CAGR of 7.28%.
September 2026
The anesthesia drugs market generated USD 7.92 billion in 2026, with prominent anesthesia drugs market companies including Envigo, JANVIER LABS, Taconic Biosciences Inc.
September 2026
The chemical recycling and dissolution of plastics market demonstrated a strong market presence in 2026 and is projected to maintain steady momentum from 2026 through 2035, supported by rising demand, expanding applications, and continued industry adoption.
September 2026
The global fibrate drugs market size was valued at USD 3.70 billion in 2026 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
September 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 106.79 million in 2026, at a CAGR of 37.38%.
September 2026
The LNP CDMO market reached USD 271.03 million in 2026, featuring leading LNP CDMO market companies such as Lonza Group, WuXi AppTec, Samsung Biologics.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The global sporicidal and sterilant chemicals market size was evaluated at USD 1.95 billion in 2026 and is predicted to hit around USD 3.34 billion by 2035, growing at a CAGR of 6.13%.
September 2026
The exosome drug delivery services market size was USD 5.70 billion in 2026, with leading exosome drug delivery services market players including CD Bioarticles, Danaher, Fujifilm, Illumina.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com